Literature DB >> 24914141

Introduction to the review series on "Advances in hematopoietic cell transplantation".

Robert S Negrin1.   

Abstract

Mesh：

Year:  2014        PMID： 24914141     DOI： 10.1182/blood-2014-05-566679

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

1.  The gp130 Cytokine Interleukin-11 Regulates Engraftment of Vav1-/- Hematopoietic Stem and Progenitor Cells in Lethally Irradiated Recipients.

Authors:  Serena De Vita; Yanhua Li; Chad E Harris; Meaghan K McGuinness; Clement Ma; David A Williams
Journal:  Stem Cells       Date:  2018-01-10       Impact factor: 6.277

Review 2.  Long-term follow-up after allogeneic stem cell transplantation.

Authors:  Inken Hilgendorf; Hildegard Greinix; Jörg P Halter; Anita Lawitschka; Hartmut Bertz; Daniel Wolff
Journal:  Dtsch Arztebl Int       Date:  2015-01-23       Impact factor: 5.594

3.  A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation.

Authors:  Johan Törlén; Olle Ringdén; Karin Garming-Legert; Per Ljungman; Jacek Winiarski; Kari Remes; Maija Itälä-Remes; Mats Remberger; Jonas Mattsson
Journal:  Haematologica       Date:  2016-08-04       Impact factor: 9.941

4.  In vivo observation of multi-phase spatiotemporal cellular dynamics of transplanted HSPCs during early engraftment.

Authors:  Soyeon Ahn; Bong Ihn Koh; Jingu Lee; Sujung Hong; Injune Kim; Pilhan Kim
Journal:  FASEB Bioadv       Date:  2022-05-13

5.  Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft-versus-host disease prophylaxis.

Authors:  Karin Garming Legert; Olle Ringdén; Mats Remberger; Johan Törlén; Jonas Mattsson; Göran Dahllöf
Journal:  Oral Dis       Date:  2020-10-27       Impact factor: 3.511
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.